Generation of a set of simple, interpretable ADMET rules of thumb

被引:702
作者
Gleeson, M. Paul [1 ]
机构
[1] GlaxoSmithKline Med Res Ctr, Stevenage SG1 2NY, Herts, England
关键词
D O I
10.1021/jm701122q
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A set of simple, consistent structure-property guides have been determined from an analysis of a number of key ADMET assays run within GSK: solubility, permeability, bioavailability, volume of distribution, plasma protein binding, CNS penetration, brain tissue binding, P-gp efflux, hERG inhibition, and cytochrome P450 1A2/2C9/2C19/2D6/3A4 inhibition. The rules have been formulated using molecular properties that chemists intuitively know how to alter in a molecule, namely, molecular weight, logP, and ionization state. The rules supplement the more predictive black-box models available to us by clearly illustrating the key underlying trends, which are in line with reports in the literature. It is clear from the analyses reported herein that almost all ADMET parameters deteriorate with either increasing molecular weight, logP, or both, with ionization state playing either a beneficial or detrimental affect depending on the parameter in question. This study re-emphasizes the need to focus on a lower molecular weight and logP area of physicochemical property space to obtain improved ADMET parameters.
引用
收藏
页码:817 / 834
页数:18
相关论文
共 113 条
  • [31] In silico prediction of blood - Brain barrier permeation using the calculated molecular cross-sectional area as main parameter
    Gerebtzoff, Gregori
    Seelig, Anna
    [J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2006, 46 (06) : 2638 - 2650
  • [32] Quantitative structure-pharmacokinetic relationship modelling: apparent volume of distribution
    Ghafourian, T
    Barzegar-Jalali, M
    Hakimiha, N
    Cronin, MTD
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 (03) : 339 - 350
  • [33] Plasma protein binding affinity and its relationship to molecular structure: An in-silico analysis
    Gleeson, M. Paul
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (01) : 101 - 112
  • [34] In silico human and rat Vss quantitative structure-activity relationship models
    Gleeson, MP
    Waters, NJ
    Paine, SW
    Davis, AM
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (06) : 1953 - 1963
  • [35] Predicting P-glycoprotein substrates by a quantitative structure-activity relationship model
    Gombar, VK
    Polli, JW
    Humphreys, JE
    Wring, SA
    Serabjit-Singh, CS
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (04) : 957 - 968
  • [36] Age-related changes in protein binding of drugs - Implications for therapy
    Grandison, MK
    Boudinot, FD
    [J]. CLINICAL PHARMACOKINETICS, 2000, 38 (03) : 271 - 290
  • [37] The impact of in vitro binding on in vitro -: In vivo extrapolations, projections of metabolic clearance and clinical drug-drug interactions
    Grime, K
    Riley, RJ
    [J]. CURRENT DRUG METABOLISM, 2006, 7 (03) : 251 - 264
  • [38] Update information on human P450s
    Guengerich, FP
    [J]. DRUG METABOLISM REVIEWS, 2002, 34 (1-2) : 7 - 15
  • [39] Characterization of SB-269970-A, a selective 5-HT7 receptor antagonist
    Hagan, JJ
    Price, GW
    Jeffrey, P
    Deeks, NJ
    Stean, T
    Piper, D
    Smith, MI
    Upton, N
    Medhurst, AD
    Middlemiss, DN
    Riley, GJ
    Lovell, PJ
    Bromidge, SM
    Thomas, DR
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (03) : 539 - 548
  • [40] Fragment-based drug design: How big is too big?
    Hajduk, Philip J.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (24) : 6972 - 6976